PRESCRIPTION
Oncology | |||||
Name of the pharmaceutical product | Active substance | Summary product characteristics | Patient information leaflet | ||
---|---|---|---|---|---|
Blastomat | Temozolamide | Reference | Reference | ||
Blastomat 100 mg | Temozolamide | Reference | Reference | ||
Blastomat 140 mg | Temozolamide | Reference | Reference | ||
Blastomat 20 mg | Temozolamide | Reference | Reference | ||
Litak 2 mg/ml – 5 ml | Cladribine | Reference | Reference | ||
Capecitabine Norameda | Capecitabine | Reference | Reference | ||
Capecitabine Norameda 150 mg Tab. N60 | Capecitabine | Reference | Reference | ||
Capecitabine Norameda 500 mg Tab. N120 | Capecitabine | Reference | Reference | ||
Docetaxel | Docetaxel | Reference | Reference | ||
Docetaxel Hospira 10 mg/ml | Docetaxel | Reference | Reference | ||
Docetaxel Teva Pharma 20 mg/ml | Docetaxel | Reference | Reference | ||
Glipox | Imatinib | Reference | Reference | ||
Glipox 400 mg | Imatinib | Reference | Reference | ||
Varlota | Erlotinib | Reference | Reference | ||
Varlota 100 mg Tab. N30 | Erlotinib | Reference | Reference | ||
Varlota 150 mg Tab. N30 | Erlotinib | Reference | Reference | ||
Inflectra 100 mg | Infliximab | Reference | Reference | ||
Topotecan Hospira 4 mg/4 ml | Topotecan | Reference | Reference | ||
Sangrel 1 mg – 5 ml N1 | Bortezomib | Reference | Reference | ||
Thromboreductin 0,5 mg Tab. N100 | Anagrelide | Reference | Reference | ||
Reseligo 3,6 mg | Goserelin | Reference | Reference | ||
Algonad 10,8 mg | Goserelin | Reference | Reference | ||
Exemestane 25 mg Tab. N30 | Exemestane | Reference | Reference | ||
Nivestim | Filgrastim | Reference | Reference | ||
Nivestim 48 MV/0,5 ml | Filgrastim | Reference | Reference | ||
Nivestim 30 MV/0,5 ml | Filgrastim | Reference | Reference | ||
Remurel | Glatiramer acetate | Reference | Reference | ||
Remurel 20mg/ml inj tirp švir 1ml N28 | Glatiramer acetate | Reference | Reference | ||
Remurel 40mg/ml inj tirp švir 1ml N28 | Glatiramer acetate | Reference | Reference |